GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NGeneBio Co Ltd (XKRX:354200) » Definitions » Interest Expense

NGeneBio Co (XKRX:354200) Interest Expense : ₩-1,804 Mil (TTM As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is NGeneBio Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. NGeneBio Co's interest expense for the three months ended in Dec. 2024 was ₩ -555 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-1,804 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. NGeneBio Co's Operating Income for the three months ended in Dec. 2024 was ₩ -4,476 Mil. NGeneBio Co's Interest Expense for the three months ended in Dec. 2024 was ₩ -555 Mil. NGeneBio Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


NGeneBio Co Interest Expense Historical Data

The historical data trend for NGeneBio Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NGeneBio Co Interest Expense Chart

NGeneBio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Expense
Get a 7-Day Free Trial -136.66 -155.25 -665.44 -1,780.58 -1,804.34

NGeneBio Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -449.53 -462.62 -395.68 -391.09 -554.96

NGeneBio Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,804 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NGeneBio Co  (XKRX:354200) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

NGeneBio Co's Interest Expense for the three months ended in Dec. 2024 was ₩-555 Mil. Its Operating Income for the three months ended in Dec. 2024 was ₩-4,476 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was ₩1,242 Mil.

NGeneBio Co's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

NGeneBio Co did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


NGeneBio Co Business Description

Traded in Other Exchanges
N/A
Address
288, Digital-ro, No. 303-307, 904ho, Guro-gu, Seoul, KOR, 08390
NGeneBio Co Ltd is engaged in the business of developing companion diagnosis, disease diagnosis, and liquid biopsy products and bioinformatics software.

NGeneBio Co Headlines

No Headlines